SCHEMBL4185164

SCHEMBL4185164

CC(=O)C(c1ccccc1)(c1ccccc1)N1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 4/20 0.57
▸ SLC6A2 P23975 3/20 0.57
▸ SLC6A4 P31645 3/20 0.57
▸ DRD3 P35462 3/20 0.57
▸ SLC6A3 Q01959 3/20 0.57
▸ CHRM2 P08172 2/20 0.57
▸ HTR1A P08908 2/20 0.57
▸ ADRA2A P08913 2/20 0.57
▸ CHRM1 P11229 2/20 0.57
▸ DRD1 P21728 2/20 0.57
▸ TBXA2R P21731 2/20 0.57
▸ ADRA1A P35348 2/20 0.57
▸ BCL2 P10415 1/20 0.57
▸ HRH3 Q9Y5N1 1/20 0.57
▸ CYP2D6 P10635 2/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ TSHR P16473 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ CACNA2D1 P54289 5/20 0.54
▸ CACNB1 Q02641 5/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5026265 0.92 KMT2A (0.59) KCNH2DRD3SLC6A3CHRM2ADRA2A
SCHEMBL3860853 0.80 OPRM1 (0.51) KCNH2DRD3SLC6A3CHRM2ADRA2A
SCHEMBL16769444 0.79 KMT2A (0.82) KCNH2SLC6A2SLC6A4DRD3SLC6A3
SCHEMBL13309468 0.79 KMT2A (0.82) KCNH2SLC6A2SLC6A4DRD3SLC6A3
SCHEMBL5026280 0.78 HRH3 (0.44) KCNH2CHRM1HRH3CYP2D6ALDH1A1
SCHEMBL13686427 0.78 KCNH2 (0.69) KCNH2SLC6A2SLC6A4DRD3SLC6A3
SCHEMBL7668121 0.78 CHRM2 (0.83) KCNH2SLC6A2SLC6A4DRD3SLC6A3
SCHEMBL4032844 0.74 KCNH2 (0.71) KCNH2SLC6A2SLC6A4DRD3SLC6A3
Chlorcyclizine SCHEMBL12157065 0.73 KCNH2 (1.00) KCNH2SLC6A2SLC6A4DRD3SLC6A3
SCHEMBL16769329 0.73 KCNH2 (0.76) KCNH2SLC6A2SLC6A4DRD3SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2019676-A2 METHOD FOR INCREASING THE BIOAVAILABILITY OF BENZHYDRYL PIPERAZINE CONTAINING COMPOUNDS Neuromed Pharmaceuticals, Ltd. (CA) 2009-02-04 — — EP claimed
WO-2007133481-A2 METHOD FOR INCREASING THE BIOAVAILABILITY OF BENZHYDRYL PIPERAZINE CONTAINING COMPOUNDS NEUROMED PHARMACEUTICALS LTD. (CA) 2007-11-22 — — WO claimed
Send feedback